摘要
Chronic hepatitis B is a worldwide disease,with significant burden on health care systems.While universal vaccination programs have led to an overall decrease in incidence of transmission of hepatitis B,unfortunately,there remain large areas in the world where vaccination against hepatitis B is not practiced.In addition,vertical transmission of hepatitis B persists as a major concern.Hepatitis B treatment of the pregnant patient requires a thorough assessment of disease activity and close monitoring for flares,regardless of initiation of antiviral therapy.We discuss,in this article,the current and emergent strategies which aim to reduce the rate of transmission of hepatitis B from the pregnant mother to the infant and we review the updated guidelines regarding management of liver disease in pregnant women with hepatitis B.
Chronic hepatitis B is a worldwide disease,with significant burden on health care systems.While universal vaccination programs have led to an overall decrease in incidence of transmission of hepatitis B,unfortunately,there remain large areas in the world where vaccination against hepatitis B is not practiced.In addition,vertical transmission of hepatitis B persists as a major concern.Hepatitis B treatment of the pregnant patient requires a thorough assessment of disease activity and close monitoring for flares,regardless of initiation of antiviral therapy.We discuss,in this article,the current and emergent strategies which aim to reduce the rate of transmission of hepatitis B from the pregnant mother to the infant and we review the updated guidelines regarding management of liver disease in pregnant women with hepatitis B.
